| Local |
BNF | Section |
| Alemtuzumab | Alemtuzumab | Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies |
| Amivantamab | Amivantamab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Atezolizumab | Atezolizumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Avelumab | Avelumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Basiliximab | Basiliximab | Immune System, Immune System Disorders And Transplantation, Immunosuppressants Monoclonal Antibodies |
| Belantamab | Belantamab Mafodotin [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Belimumab | Belimumab | Immune System, Immune System Disorders And Transplantation, Immunosuppressants Monoclonal Antibodies |
| Benralizumab | Benralizumab | Respiratory System, Airways Disease, Obstructive, Immunosuppressants Monoclonal Antibodies |
| Bevacizumab | Bevacizumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Blinatumomab | Blinatumomab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Brentuximab | Brentuximab Vedotin [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Burosumab | Burosumab | Nutrition And Metabolic Disorders, Fluid And Electrolyte Imbalances, Phosphate Imbalance, Drugs Affecting Bone Structure And Mineralisation Monoclonal Antibodies |
| Canakinumab | Canakinumab | Immune System, Immune System Disorders And Transplantation, Immunosuppressants Monoclonal Antibodies |
| Canakinumab | Canakinumab | Musculoskeletal System, Hyperuricaemia And Gout, Immunosuppressants Monoclonal Antibodies |
| Cemiplimab | Cemiplimab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Cetuximab | Cetuximab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Daratumumab | Daratumumab | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Denosumab | Denosumab | Endocrine System, Bone Metabolism Disorders, Drugs Affecting Bone Structure And Mineralisation Monoclonal Antibodies |
| Denosumab | Denosumab | Malignant Disease, Secondary Bone Metastases And Hypercalcaemia, Drugs Affecting Bone Structure And Mineralisation Monoclonal Antibodies |
| Dinutuximab | Dinutuximab Beta [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Dostarlimab | Dostarlimab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Durvalumab | Durvalumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Elotuzumab | Elotuzumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Elranatamab | Elranatamab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Enfortumab | Enfortumab Vedotin [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Epcoritamab | Epcoritamab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Gemtuzumab | Gemtuzumab Ozogamicin [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Glofitamab | Glofitamab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Inotuzumab | Inotuzumab Ozogamicin [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Ipilimumab | Ipilimumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Isatuximab | Isatuximab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Loncastuximab | Loncastuximab Tesirine [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Mepolizumab | Mepolizumab | Respiratory System, Airways Disease, Obstructive, Immunosuppressants Monoclonal Antibodies |
| Mirvetuximab | Mirvetuximab Soravtansine [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Mogamulizumab | Mogamulizumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Mosunetuzumab | Mosunetuzumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Natalizumab | Natalizumab | Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies |
| Nivolumab | Nivolumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Nivolumab | Nivolumab With Relatlimab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Obinutuzumab | Obinutuzumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Ocrelizumab | Ocrelizumab | Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies |
| Ofatumumab | Ofatumumab | Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies |
| Omalizumab | Omalizumab | Respiratory System, Airways Disease, Obstructive, Immunosuppressants Monoclonal Antibodies |
| Omalizumab | Omalizumab | Skin, Inflammatory Skin Conditions, Urticaria, Immunosuppressants Monoclonal Antibodies |
| Palivizumab | Palivizumab | Anti-Infective, Viral Infection, Respiratory Syncytial Virus, Drugs For Respiratory Diseases Monoclonal Antibodies |
| Panitumumab | Panitumumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Pembrolizumab | Pembrolizumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Pertuzumab | Pertuzumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Pertuzumab | Pertuzumab With Trastuzumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Polatuzumab | Polatuzumab Vedotin [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Ramucirumab | Ramucirumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Reslizumab | Reslizumab | Respiratory System, Airways Disease, Obstructive, Immunosuppressants Monoclonal Antibodies |
| Rituximab | Rituximab | Immune System, Immune System Disorders And Transplantation, Antineoplastic Drugs Monoclonal Antibodies |
| Rituximab | Rituximab | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Rituximab | Rituximab | Musculoskeletal System, Arthritis, Antineoplastic Drugs Monoclonal Antibodies |
| Romosozumab | Romosozumab | Endocrine System, Bone Metabolism Disorders, Drugs Affecting Bone Structure And Mineralisation Monoclonal Antibodies |
| Rozanolixizumab | Rozanolixizumab | Musculoskeletal System, Neuromuscular Disorders, Myasthenia Gravis And Lambert-Eaton Myasthenic Syndrome, Immunosuppressants Monoclonal Antibodies |
| Sacituzumab | Sacituzumab Govitecan [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Siltuximab | Siltuximab | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Sotrovimab | Sotrovimab | Anti-Infective, Viral Infection, Coronavirus, Antivirals SARS-Cov-2 Neutralising Monoclonal Antibodies |
| Tafasitamab | Tafasitamab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Talquetamab | Talquetamab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Teclistamab | Teclistamab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Tezepelumab | Tezepelumab | Respiratory System, Airways Disease, Obstructive, Immunosuppressants Monoclonal Antibodies |
| Trastuzumab | Trastuzumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Trastuzumab | Trastuzumab Deruxtecan [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Trastuzumab | Trastuzumab Emtansine [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Tremelimumab | Tremelimumab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |
| Ublituximab | Ublituximab | Immune System, Immune System Disorders And Transplantation, Multiple Sclerosis, Immunosuppressants Monoclonal Antibodies |
| Vedolizumab | Vedolizumab | Gastro-Intestinal System, Chronic Bowel Disorders, Inflammatory Bowel Disease, Immunosuppressants Monoclonal Antibodies |
| Zolbetuximab | Zolbetuximab [Specialist Drug] | Malignant Disease, Antibody Responsive Malignancy, Antineoplastic Drugs Monoclonal Antibodies |